The US Food and Drug administration (FDA) has given approvals to Moderna and Johnson & Johnson (J&J) to authorize boosters. By using a mix and match approach, the FDA has authorized the boosters for all populations eligible to receive one under the emergency use authorization currently in place. Elaborating on the authorization, a booster is recommended for the one-dose J&J vaccine, with recipients having the choice between receiving another J&J vaccine or Moderna’s mRNA vaccine. Similarly, people who received Moderna now have the option of receiving a J&J vaccine. Moderna boosters though are currently only authorized for people aged 65+ years old or have an increased risk of developing severe disease.
Read more here.
Don’t miss the next article from HealthFirst 100.
Join our mailing list to receive the latest posts from our blog directly in your inbox.